NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/24/2024
Back to search
Official data from USPTO
ACKERMAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
08/24/2024
Classification
Registered
Trademark type
Combined
Nice classes
44
Filing date
08/25/2014
Registration date
04/07/2015
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/24/2024
Last transaction
08/24/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/08/2014
First use in commerce
09/08/2014
Drawing code
3
Owner type
03
Owner location
Jacksonville, FL, US
Examiner
CHUO, EMILY M
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of A circular design consisting of triangles, tear drops and circles with the word "ACKERMAN " below it.
Holders and representatives
Holders
Ackerman Cancer Center, P.A.
Representatives
David J. Hrina BRENNAN MANNA & DIAMOND, LLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Health care services for treating cancer; Medical diagnosis and treatment of cancer; Medical diagnosis of cancer; Medical dosimetry services for treating cancer; Medical evaluation of cancer; Medical imaging services; Medical radiology services; Medical services in the field of cancer; Medical services, namely,cancer; Medical testing for diagnostic or treatment purposes in the field of cancer; Medical treatment of cancer; Providing a website featuring information in the field of the diagnosis and treatment of cancer; Providing cancer screening services; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Providing links to the web sites of others featuring information about the diagnosis and treatment of cancer
Publications
History of USPTO decisions and trademark events.
25 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/24/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/24/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/24/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
06/10/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/07/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/30/2022
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/30/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/29/2022
ES8R
TEAS SECTION 8 RECEIVED
09/13/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/20/2015
PUBO
PUBLISHED FOR OPPOSITION
01/20/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/31/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2014
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
12/10/2014
IUAA
USE AMENDMENT ACCEPTED
12/09/2014
DOCK
ASSIGNED TO EXAMINER
12/09/2014
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
09/17/2014
IUAF
USE AMENDMENT FILED
09/17/2014
EAAU
TEAS AMENDMENT OF USE RECEIVED
09/16/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/09/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2014
NWAP
NEW APPLICATION ENTERED
08/28/2014
Continuous trademark protection
Get notified about every new filing that threatens ACKERMAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.